• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从蓝桉中分离出的巨桉酚C以聚集形式抑制二肽基肽酶4。

Macrocarpal C isolated from Eucalyptus globulus inhibits dipeptidyl peptidase 4 in an aggregated form.

作者信息

Kato Eisuke, Kawakami Kazuhiro, Kawabata Jun

机构信息

a Laboratory of Food Biochemistry, Division of Applied Bioscience, Graduate School of Agriculture , Hokkaido University , Kita-ku , Hokkaido , Japan Sapporo.

出版信息

J Enzyme Inhib Med Chem. 2018 Dec;33(1):106-109. doi: 10.1080/14756366.2017.1396458.

DOI:10.1080/14756366.2017.1396458
PMID:29148282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6009884/
Abstract

Dipeptidyl peptidase 4 (DPP-4) inhibitors are used for the treatment of type-2 diabetes mellitus. Various synthetic inhibitors have been developed to date, and plants containing natural DPP-4 inhibitors have also been identified. Here, 13 plant samples were tested for their DPP-4 inhibitory activity. Macrocarpals A-C were isolated from Eucalyptus globulus through activity-guided fractionation and shown to be DPP-4 inhibitors. Of these, macrocarpal C showed the highest inhibitory activity, demonstrating an inhibition curve characterised by a pronounced increase in activity within a narrow concentration range. Evaluation of macrocarpal C solution by turbidity, nuclear magnetic resonance spectroscopy and mass spectrometry indicated its aggregation, which may explain the characteristics of the inhibition curve. These findings will be valuable for further study of potential small molecule DPP-4 inhibitors.

摘要

二肽基肽酶4(DPP-4)抑制剂用于治疗2型糖尿病。迄今为止,已开发出多种合成抑制剂,同时也鉴定出了含有天然DPP-4抑制剂的植物。在此,对13个植物样本进行了DPP-4抑制活性测试。通过活性导向分级分离从蓝桉中分离出大果桉醇A-C,结果表明它们是DPP-4抑制剂。其中,大果桉醇C表现出最高的抑制活性,其抑制曲线的特征是在狭窄的浓度范围内活性显著增加。通过浊度、核磁共振光谱和质谱对大果桉醇C溶液进行评估,结果表明其发生了聚集,这可能解释了抑制曲线的特征。这些发现对于进一步研究潜在的小分子DPP-4抑制剂具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e2/6009884/024e34a5e252/IENZ_A_1396458_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e2/6009884/d43b994282c1/IENZ_A_1396458_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e2/6009884/ed002a673c38/IENZ_A_1396458_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e2/6009884/024e34a5e252/IENZ_A_1396458_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e2/6009884/d43b994282c1/IENZ_A_1396458_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e2/6009884/ed002a673c38/IENZ_A_1396458_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35e2/6009884/024e34a5e252/IENZ_A_1396458_F0003_B.jpg

相似文献

1
Macrocarpal C isolated from Eucalyptus globulus inhibits dipeptidyl peptidase 4 in an aggregated form.从蓝桉中分离出的巨桉酚C以聚集形式抑制二肽基肽酶4。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):106-109. doi: 10.1080/14756366.2017.1396458.
2
[Studies on chemical constituents in fruits of Eucalyptus globulus].[蓝桉果实化学成分的研究]
Zhongguo Zhong Yao Za Zhi. 2007 Mar;32(6):496-500.
3
Semisynthesis of macrocarpal C and analogues by selective dehydration of macrocarpal A or B.通过对大苞鞘石斛 A 或 B 的选择性脱水来半合成大苞鞘石斛 C 及其类似物。
J Nat Prod. 2013 Dec 27;76(12):2346-9. doi: 10.1021/np400869z. Epub 2013 Nov 21.
4
Eucalyptone from Eucalyptus globulus.蓝桉中的桉叶油素。
Phytochemistry. 1995 Sep;40(1):183-4. doi: 10.1016/0031-9422(95)00233-w.
5
Euglobal-In-1, a new euglobal from Eucalyptus incrassata.尤全球 - 1,一种来自厚皮桉的新型尤全球。
Chem Pharm Bull (Tokyo). 1994 Oct;42(10):2113-6. doi: 10.1248/cpb.42.2113.
6
Macrocarpals H, I, and J from the Leaves of Eucalyptus globulus.蓝桉树叶中的大果桉醇H、I和J。
J Nat Prod. 1996 Sep;59(9):823-7. doi: 10.1021/np9604994.
7
Tyrosinase inhibitors from the leaves of Eucalyptus globulus.从桉树叶子中提取的酪氨酸酶抑制剂。
Fitoterapia. 2019 Nov;139:104418. doi: 10.1016/j.fitote.2019.104418. Epub 2019 Nov 5.
8
Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.作为二肽基肽酶-4(DPP-4)抑制剂的三唑并三嗪衍生物的设计、合成及抗糖尿病活性
Bioorg Chem. 2017 Jun;72:345-358. doi: 10.1016/j.bioorg.2017.03.004. Epub 2017 Mar 6.
9
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.二肽基肽酶-4 抑制剂治疗 2 型糖尿病的研究进展。
Eur J Med Chem. 2018 May 10;151:145-157. doi: 10.1016/j.ejmech.2018.03.041. Epub 2018 Mar 21.
10
The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.新型5,6,5-和5,5,6-三环吡咯烷作为强效和选择性二肽基肽酶-4抑制剂的发现。
Bioorg Med Chem Lett. 2016 Jun 1;26(11):2622-6. doi: 10.1016/j.bmcl.2016.04.020. Epub 2016 Apr 9.

引用本文的文献

1
Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs the modulation of AKT-signaling pathway in Alzheimer's disease.二肽基肽酶-4抑制剂和胰高血糖素样肽-1类似物对阿尔茨海默病中AKT信号通路的调节作用及其神经保护作用
World J Biol Chem. 2021 Nov 27;12(6):104-113. doi: 10.4331/wjbc.v12.i6.104.
2
Improvements in HOMA indices and pancreatic endocrinal tissues in type 2-diabetic rats by DPP-4 inhibition and antioxidant potential of an ethanol fruit extract of Withania coagulans.通过抑制二肽基肽酶-4以及醉茄乙醇果实提取物的抗氧化潜力改善2型糖尿病大鼠的HOMA指数和胰腺内分泌组织。
Nutr Metab (Lond). 2021 Apr 21;18(1):43. doi: 10.1186/s12986-021-00547-2.

本文引用的文献

1
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.2型糖尿病的药物治疗:现有疗法
Am J Cardiol. 2017 Jul 1;120(1S):S4-S16. doi: 10.1016/j.amjcard.2017.05.009. Epub 2017 May 30.
2
The Antidiabetic Mechanisms of Polyphenols Related to Increased Glucagon-Like Peptide-1 (GLP1) and Insulin Signaling.多酚与胰高血糖素样肽-1(GLP1)增加及胰岛素信号传导相关的抗糖尿病机制
Molecules. 2017 May 30;22(6):903. doi: 10.3390/molecules22060903.
3
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
2型糖尿病的药物治疗:现有疗法
Am J Med. 2017 Jun;130(6S):S4-S17. doi: 10.1016/j.amjmed.2017.04.004.
4
8. Pharmacologic Approaches to Glycemic Treatment.8. 血糖治疗的药理学方法。
Diabetes Care. 2017 Jan;40(Suppl 1):S64-S74. doi: 10.2337/dc17-S011.
5
Isolation of rugosin A, B and related compounds as dipeptidyl peptidase-IV inhibitors from rose bud extract powder.从玫瑰花蕾提取物粉末中分离出鲁戈辛A、B及相关化合物作为二肽基肽酶-IV抑制剂。
Biosci Biotechnol Biochem. 2016 Nov;80(11):2087-2092. doi: 10.1080/09168451.2016.1214533. Epub 2016 Aug 1.
6
Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.肠促胰岛素疗法:强调胰高血糖素样肽-1受体激动剂和二肽基肽酶-4抑制剂作用模式的共同特征与差异
Diabetes Obes Metab. 2016 Mar;18(3):203-16. doi: 10.1111/dom.12591. Epub 2016 Jan 5.
7
Semisynthesis of macrocarpal C and analogues by selective dehydration of macrocarpal A or B.通过对大苞鞘石斛 A 或 B 的选择性脱水来半合成大苞鞘石斛 C 及其类似物。
J Nat Prod. 2013 Dec 27;76(12):2346-9. doi: 10.1021/np400869z. Epub 2013 Nov 21.
8
Determining the stoichiometry and interactions of macromolecular assemblies from mass spectrometry.通过质谱法确定大分子组装体的化学计量和相互作用。
Nat Protoc. 2007;2(3):715-26. doi: 10.1038/nprot.2007.73.
9
Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.肥胖2型糖尿病患者和健康受试者中胰高血糖素样肽-1的清除率相似。
J Clin Endocrinol Metab. 2003 Jan;88(1):220-4. doi: 10.1210/jc.2002-021053.
10
Isolation and characterization of macrocarpals B--G antibacterial compounds from Eucalyptus macrocarpa.从大果桉中分离并鉴定大果桉B - G抗菌化合物
Biosci Biotechnol Biochem. 1992 Oct;56(10):1570-6. doi: 10.1271/bbb.56.1570.